Associations between Th1-mediated diseases and omalizumab: A post-marketing study of the World Health Organization pharmacovigilance database (VigiBase (R)) - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Fundamental & Clinical Pharmacology Année : 2022

Associations between Th1-mediated diseases and omalizumab: A post-marketing study of the World Health Organization pharmacovigilance database (VigiBase (R))

, , (1) , (2, 3, 1, 4, 5) , ,
1
2
3
4
5
Fichier non déposé

Dates et versions

hal-03712138 , version 1 (02-07-2022)

Identifiants

  • HAL Id : hal-03712138 , version 1

Citer

S. Magnifico, A. Dernoncourt, K. Masmoudi, S. Liabeuf, V. Gras-Champel, et al.. Associations between Th1-mediated diseases and omalizumab: A post-marketing study of the World Health Organization pharmacovigilance database (VigiBase (R)). Fundamental & Clinical Pharmacology, 2022, 36 (1, SI), pp.14-15. ⟨hal-03712138⟩
19 Consultations
0 Téléchargements

Partager

Gmail Facebook Twitter LinkedIn More